+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Analgesics in Lithuania

  • PDF Icon

    Report

  • 24 Pages
  • October 2023
  • Region: Lithuania
  • Euromonitor International
  • ID: 1345731
Analgesics is failing to record a strong performance in Lithuania in 2023; following the pandemic years, sales are stagnating, reflecting the saturated market and consumer base. In addition, a growing scepticism and concern about the overreliance on analgesics is impacting sales. However, positively, paediatric analgesics are very well received, being the major measure against fevers, a common condition seen in children during seasonal colds and flu.

The Analgesics in Lithuania report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Analgesics market
  • Pinpoint growth sectors and identify factors driving change
  • Understand the competitive environment, the market’s major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

ANALGESICS IN LITHUANIAKEY DATA FINDINGS
2023 DEVELOPMENTS
  • Results stagnate; however, paediatric analgesics boost sales
  • Ibuprofen brands dominate as US Pharmacia Sp retains its lead
  • Combination analgesics lose ground as consumers become increasingly cautious
PROSPECTS AND OPPORTUNITIES
  • Analgesics suffer from a lack of innovation as growing concerns challenge sales
  • Paediatric options to continue performing well over the forecast period
  • Emergence of modern grocery retailers for the distribution of analgesics set to benefit sales
CATEGORY DATA
  • Table 1 Sales of Analgesics by Category: Value 2018-2023
  • Table 2 Sales of Analgesics by Category: % Value Growth 2018-2023
  • Table 3 NBO Company Shares of Analgesics: % Value 2019-2023
  • Table 4 LBN Brand Shares of Analgesics: % Value 2020-2023
  • Table 5 Forecast Sales of Analgesics by Category: Value 2023-2028
  • Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2023-2028
CONSUMER HEALTH IN LITHUANIA
EXECUTIVE SUMMARY
  • Consumer health in 2023: The big picture
  • 2023 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?
MARKET INDICATORS
  • Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
  • Table 8 Life Expectancy at Birth 2018-2023
MARKET DATA
  • Table 9 Sales of Consumer Health by Category: Value 2018-2023
  • Table 10 Sales of Consumer Health by Category: % Value Growth 2018-2023
  • Table 11 NBO Company Shares of Consumer Health: % Value 2019-2023
  • Table 12 LBN Brand Shares of Consumer Health: % Value 2020-2023
  • Table 13 Penetration of Private Label by Category: % Value 2018-2023
  • Table 14 Distribution of Consumer Health by Format: % Value 2018-2023
  • Table 15 Distribution of Consumer Health by Format and Category: % Value 2023
  • Table 16 Forecast Sales of Consumer Health by Category: Value 2023-2028
  • Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
DISCLAIMERDEFINITIONS
SOURCES
  • Summary 1 Research Sources